- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 17/10 - Anti-acne agents
Patent holdings for IPC class A61P 17/10
Total number of patents in this class: 1659
10-year publication summary
|
37
|
47
|
90
|
125
|
135
|
130
|
150
|
105
|
127
|
85
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Galderma Research & Development | 398 |
66 |
| Pierre Fabre Dermo-Cosmetique | 371 |
28 |
| Beiersdorf AG | 3026 |
26 |
| DSM IP Assets B.V. | 5581 |
23 |
| Sol-gel Technologies Ltd. | 128 |
23 |
| S-Biomedic NV | 37 |
20 |
| Kenvue Brands LLC | 969 |
20 |
| L' Oréal | 5547 |
19 |
| Conopco, Inc. | 4996 |
18 |
| Bausch Health Ireland Limited | 795 |
18 |
| The Regents of the University of California | 20059 |
17 |
| Galderma S.A. | 140 |
17 |
| Allergan, Inc. | 2337 |
15 |
| Unilever Global IP Limited | 2030 |
15 |
| Mayne Pharma LLC | 53 |
14 |
| Journey Medical Corporation | 94 |
12 |
| Novartis AG | 10730 |
11 |
| Johnson & Johnson Consumer Inc. | 354 |
11 |
| Unilever IP Holdings B.V. | 3100 |
11 |
| Colgate-Palmolive Company | 5782 |
10 |
| Other owners | 1265 |